Biotage CEO & President steps down from his role
While the business of Biotage continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of Biotage AB with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new CEO is finalized.
“The Board wishes to thank Tomas Blomquist for the four years he has led the company. During turbulent times, not the least the effects from geopolitical events and a global pandemic, the company has doubled in size under his leadership. As we embark on a new growth phase in Biotage we have agreed that there is a need for change and that new leadership with a different profile is needed to take an already successful company to the next level “ says Torben Jørgensen, Chairman of the Board.
As Torben Jørgensen takes on the role as interim CEO, he has resigned as Chairman of the Board but he will remain as a Board member. Kieran Murphy has been appointed as Chairman of the Board during Torben Jørgensen’s period as interim CEO, which has been decided in dialogue with the Nomination Committee. Kieran Murphy also takes Torben Jørgensen’s role as acting member of the Nomination Committee.
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
